Zobrazeno 1 - 10
of 234
pro vyhledávání: ''
Autor:
Claudia da Costa Leite, Márcio Gerhardt Soeiro-de-Souza, E. Scotti-Muzzi, Fernando Fernandes, Rodrigo Machado-Vieira, R. T. De Sousa, Maria Concepcion Garcia Otaduy
Publikováno v:
European Neuropsychopharmacology. 49:93-100
The diagnosis and treatment of bipolar depression (BDep) poses complex clinical challenges for psychiatry. Proton magnetic resonance spectroscopy (1H-MRS) is a useful imaging tool for investigating in vivo levels of brain neuro-metabolites, critical
Autor:
Michele Verde-Ramo Soares, Alana Gomes de Souza, Adriano José Maia Chaves Filho, Danielle Silveira Macêdo, Tatiana de Queiroz, Paloma Marinho Jucá, Natássia Lopes Cunha, Carolina Horta Andrade, Dino César da Silva Clemente, Melina Mottin, Christina Alves Peixoto, Patrícia de Araújo Rodrigues
Publikováno v:
European Neuropsychopharmacology. 42:57-74
Immune-inflammatory mechanisms are involved in the pathophysiology of bipolar disorder. Tetracyclines present neuroprotective actions based on their anti-inflammatory and microglia suppressant effects. Doxycycline (DOXY) is a tetracycline that demons
Autor:
Claudia Pisanu, Alessio Squassina, Paola Niola, Donatella Congiu, Cristiana Cruceanu, Martin Alda, Maria Del Zompo, Raffaella Ardau, Giovanni Severino, Juan Pablo Lopez, Gustavo Turecki, Caterina Chillotti
Publikováno v:
European Neuropsychopharmacology. 34:39-49
Post-mortem brain studies suggest that miRNAs may be involved in suicide, but their role as peripheral biomarkers or targets of preventive pharmacological treatments in suicide has yet to be elucidated. We used nCounter miRNA Expression assay to meas
Publikováno v:
European Neuropsychopharmacology. 31:16-32
Lithium is the first line therapy of bipolar mood disorder. Lithium-induced nephrogenic diabetes insipidus (Li-NDI) and lithium nephropathy (Li-NP, i.e., renal insufficiency) are prevalent side effects of lithium therapy, with significant morbidity.
Autor:
Purificación López-Peña, C. Bermúdez-Ampudia, Eduard Vieta, Mónica Martínez-Cengotitabengoa, Ana González-Pinto
Publikováno v:
European Neuropsychopharmacology. 28:1351-1359
To critically examine the effectiveness of lithium in preventing depressive symptoms (mixed and depressive episodes) in real life settings, taking into account adherence to drug treatment and its implications for the clinical costs of the disease. Ov
Autor:
Alessandro Serretti, Julien Mendlewicz, Joseph Zohar, Stuart Montgomery, Alexander Kautzky, Siegfried Kasper, Daniel Souery, Stefano Porcelli, Lucie Bartova, Markus Dold
Publikováno v:
European Neuropsychopharmacology. 28:1305-1313
This cross-sectional European multicenter study with retrospective assessment of treatment response sought to determine variables associated with the administration of augmentation strategies with second-generation antipsychotics (SGAs) and lithium i
Publikováno v:
European Neuropsychopharmacology. 51:e181
Autor:
Scott R. Clark, Bernhard T. Baune, Anbupalam Thalamuthu, Klaus Oliver Schubert, Marcella Rietschel, Thomas G. Schulze, Azmeraw T. Amare
Publikováno v:
European Neuropsychopharmacology. 51:e231
Publikováno v:
European Neuropsychopharmacology. 51:e35
Publikováno v:
European Neuropsychopharmacology. 51:e158